Zenas BioPharma (ZBIO) Other Gross PP&E Adjustments (2023 - 2025)

Zenas BioPharma (ZBIO) has 3 years of Other Gross PP&E Adjustments data on record, last reported at -$2.7 million in Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments fell 15.5% year-over-year to -$2.7 million; the TTM value through Sep 2025 reached -$2.7 million, down 15.5%, while the annual FY2024 figure was -$2.3 million, 12.94% down from the prior year.
  • Other Gross PP&E Adjustments reached -$2.7 million in Q3 2025 per ZBIO's latest filing, down from -$2.0 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$2.0 million in Q4 2023 and bottomed at -$2.7 million in Q3 2025.
  • Average Other Gross PP&E Adjustments over 3 years is -$2.2 million, with a median of -$2.2 million recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: fell 12.94% in 2024, then fell 15.5% in 2025.
  • A 3-year view of Other Gross PP&E Adjustments shows it stood at -$2.0 million in 2023, then fell by 12.94% to -$2.3 million in 2024, then fell by 20.19% to -$2.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$2.7 million in Q3 2025, -$2.0 million in Q2 2025, and -$2.0 million in Q1 2025.